A collaboration between researchers at Karlstad University and Bluelight has resulted in a publication exploring motivations for novel substance use in the International Journal of Drug Policy.
The study was promoted exclusively through Bluelight's banner over a 3 month period. 619 users of novel substances responded to the survey, describing a total of 1551 uses of novel substances (up to 3 per respondent).
We would like to congratulate Christophe Soussan and Professor Anette Kjellgren on their successful publication. We are especially grateful for their decision to make the publication open access, so anyone in our community can read it.
If you are a researcher interested in collaborating with us, please see our Research Portal for more information or contact us directly.
With long-standing excitement, I'd like to announce the creation of a new platform for discussing the rising cultural phenomenon of vaping. Primarily applied to the rising global prevalence of "electronic cigarettes," vaping represents one of the more visible harm reduction hot topics across the world.
The new forum, entitled Vaping Discussion, pertains to all discussion surrounding the science, news, health, culture, safety, hardware, etc. of electronic cigarettes/mods/APVs/ENDS/whatever you'd prefer they be called!
As a special nod to the long-standing practice of vaping as it presents in the communities of our Cannabis-consuming members, the parent forum 'Vaping Discussion' includes a sub-forum within it for all things related to vaping cannabis, and is called Cannabis Vaping Discussion.
Though I'll be spending a great deal of time involving myself with both forums as they start up and begin to expand and evolve, we've appointed two...
We are pleased to announce the appointment of Bluelight's new research assistant - Cameron Norton, from Melbourne, Australia.
Cameron has a background in psychology and languages and has spent most of the past 10 years living in Europe and Asia. Building on a long-standing interest in the field, he recently transitioned into working in one of Melbourne’s largest alcohol and other drug treatment agencies. Cameron is passionate about reducing the stigma attached to substance use and promoting a well-informed and rational discussion about how to make substance use safe and non-destructive. As research assistant he hopes to increase the profile of Bluelight in the research community and improve communication between bluelight users and researchers.
Cameron will be working with me (Monica Barratt) maintaining and growing the research aspects of Bluelight. I'm looking forward to having someone to assist with these tasks as well as to introduce their own ideas about how best to make...
Bluelight is bidding a fond farewell to alasdairm who has decided after many years to step down from heading BL's Admin team. It is no secret that he has contributed more than could possibly be condensed within a single post. Ali has been the role model for generations of BL staff of all levels. His positive energies superseded mere staffing, and indeed his guiding hand and sound thinking stretched to all corners of the community. My personal indebtedness to his character both goes very far and runs very deep.
Bluelight will miss having you in its repertoire. As a community, we can be grateful that you're not leaving the site itself!
Despite Ali's departure, it is with great optimism and gratitude that Bluelight announces its three newest additions to the Administrative Staff!
Please join us in welcoming ebola?, sekio and baooozs to the team!
It's been a short while since Bluelight has had a full-sized team at the administrative level...
BLUELIGHT.ORG: Reducing Harm by Educating the Individual
Bluelight is an international, online harm-reduction community, committed to reducing the harm associated with drug use.
Bluelight neither condones nor condemns the use of drugs. Rather, we accept that drug use will always exist irrespective of legal status or societal norms. While there is no truly safe way to use drugs, we understand that prohibition and abstinence are not realistic or desirable solutions for everyone, nor have they been adequate in addressing the serious public health concerns associated with drug use.
While there is no universal definition of drug-related harm reduction, Bluelight believes that through frank and open discussion we are able to deliver accurate information, eliminate misinformation and empower individuals to make wiser, more responsible choices.
Bluelight understands that drug use encompasses a broad range of behaviors, some safer than others, and that drug use can progress...
Have you ever wondered how Bluelight stays online?
Bluelight co-owners have ensured the survival of the website after our benefactor passed away. There were a few options for us to establish our own revenue streams:
1. Constantly run donation drives (annoying to members, diverts from our focus, extremely time consuming for senior staff, and probably wouldn't be sufficient to pay our bills)
2. Sell advertising to the highest bidder (even more annoying to our members, clutters the site, diverts from our focus)
3. Paid memberships: defeats the purpose of providing harm reduction to the masses and would likely fail, anyway
4. Collaborate with researchers: (May have some hypothetical/theoretical drawbacks, but has many practical benefits, not the least of which includes going Bluelight an opportunity to directly contribute to the growing body of scientific research)
For many reasons we believe the last option provides Bluelight with the most benefit and least...